Rapid and strong antiviral activity of the non-nucleosidic NS5B polymerase inhibitor BI 207127 in combination with peginterferon alfa 2a and ribavirin

Authors: Larrey, Dominique, Lohse, Ansgar W., de Ledinghen, Victor, Trepo, Christian, Gerlach, Tilman, Zarski, Jean-Pierre, Tran, Albert, Mathurin, Philippe, Thimme, Robert, Arastéh, Keikawus, Trautwein, Christian, Cerny, Andreas, Dikopoulos, Nektarios, Schuchmann, Marcus, Heim, Markus H., Gerken, Guido, Stern, Jerry O., Wu, Katherine, Abdallah, Nasri, Girlich, Birgit, Scherer, Joseph, Berger, Frank, Marquis, Martin, Kukolj, George, Böcher, Wulf, Steffgen, Jürgen

Source: In Journal of Hepatology July 2012 57(1):39-46

Importance of Minimal Residual Viremia for Relapse Prediction in Patients With Chronic Hepatitis C Genotype 1 Infection

Authors: Wiegand, Johannes, Neumann, Konrad, Böhm, Stephan, Weich, Viola, Teuber, Gerlinde, Klinker, Hartwig, Möller, Bernd, Rasenack, Jens, Hinrichsen, Holger, Gerlach, Tilman, Spengler, Ulrich, Buggisch, Peter, Sarrazin, Christoph, Berg, Thomas

Source: Clinical Infectious Diseases, 2011 Dec 01. 53(11), 1111-1114.

Access URL: http://dx.doi.org/10.1093/cid/cir670

Antigen Kinetics Determines Immune Reactivity

Authors: Johansen, Pål, Storni, Tazio, Rettig, Lorna, Qiu, Zhiyong, Der-Sarkissian, Ani, Smith, Kent A., Manolova, Vania, Lang, Karl S., Senti, Gabriela, Müllhaupt, Beat, Gerlach, Tilman, Speck, Roberto F., Bot, Adrian, Kündig, Thomas M.

Source: Proceedings of the National Academy of Sciences of the United States of America, 2008 Apr 01. 105(13), 5189-5194.

Access URL: https://www.jstor.org/stable/25461575

Viral genotype-specific role of PNPLA3, PPARG, MTTP, and IL28B in hepatitis C virus-associated steatosis

Authors: Cai, Tao, Dufour, Jean-François, Muellhaupt, Beat, Gerlach, Tilman, Heim, Markus, Moradpour, Darius, Cerny, Andreas, Malinverni, Raffaele, Kaddai, Vincent, Bochud, Murielle, Negro, Francesco, Bochud, Pierre-Yves

Source: In Journal of Hepatology September 2011 55(3):529-535

Association of Hepatitis C Virus-Specific CD8⁺ T Cells with Viral Clearance in Acute Hepatitis C

Authors: Grüner, Norbert H., Gerlach, Tilman J., Jung, Maria-Christina, Diepolder, Helmut M., Schirren, Carl Albrecht, Schraut, Winfried W., Hoffmann, Robert, Zachoval, Reinhart, Santantonio, Teresa, Cucchiarini, M., Cerny, Andreas, Pape, Gerd R.

Source: The Journal of Infectious Diseases, 2000 May 01. 181(5), 1528-1536.

Access URL: https://www.jstor.org/stable/30110199

Characterization of sequence variations in immunodominant regions of the HBV-nucleocapsid protein as a prerequisite for the development of an epitope-based vaccine

Authors: Gruener, Norbert H., Gerlach, Tilman J., Ulsenheimer, Axel, Diepolder, Helmut M., Wierenga, Eddy, Zachoval, Reinhart, Heeg, Malte, Pape, Gerd Rudolf, Jung, Maria-Christina

Source: In Vaccine 2007 25(26):4960-4966

Extended Treatment Duration for Hepatitis C Virus Type 1: Comparing 48 Versus 72 Weeks of Peginterferon-Alfa-2a Plus Ribavirin

Authors: Berg, Thomas, von Wagner, Michael, Nasser, Samer, Sarrazin, Christoph, Heintges, Tobias, Gerlach, Tilman, Buggisch, Peter, Goeser, Tobias, Rasenack, Jens, Pape, Gerd R., Schmidt, Wolfgang E., Kallinowski, Birgit, Klinker, Hartwig, Spengler, Ulrich, Martus, Peter, Alshuth, Ulrich, Zeuzem, Stefan

Source: In Gastroenterology April 2006 130(4):1086-1097

Triple therapy with amantadine in treatment-naive patients with chronic hepatitis C: A placebo-controlled trial

Authors: Berg, Thomas, Kronenberger, Bernd, Hinrichsen, Holger, Gerlach, Tilman, Buggisch, Peter, Herrmann, Eva, Spengler, Ulrich, Goeser, Tobias, Nasser, Samer, Wursthorn, Karsten, Pape, Gerd R., Hopf, Uwe, Zeuzem, Stefan

Source: In Hepatology 2003 37(6):1359-1367

Prediction of treatment outcome in patients with chronic hepatitis C: Significance of baseline parameters and viral dynamics during therapy

Authors: Berg, Thomas, Sarrazin, Christoph, Herrmann, Eva, Hinrichsen, Holger, Gerlach, Tilman, Zachoval, Reinhart, Wiedenmann, Bertram, Hopf, Uwe, Zeuzem, Stefan

Source: In Hepatology 2003 37(3):600-609

Immunological monitoring during therapeutic vaccination as a prerequisite for the design of new effective therapies: induction of a vaccine-specific CD4+ T-cell proliferative response in chronic hepatitis B carriers

Authors: Jung, Maria-Christina, Grüner, Norbert, Zachoval, Reinhart, Schraut, Winfried, Gerlach, Tilman, Diepolder, Helmut, Schirren, Carl-Albrecht, Page, Mark, Bailey, John, Birtles, Emma, Whitehead, Eve, Trojan, Jörg, Zeuzem, Stefan, Pape, Gerd R

Source: In Vaccine 2002 20(29):3598-3612

Vigorous Peripheral Blood Cytotoxic T Cell Response during the Acute Phase of Hepatitis C Virus Infection

Authors: Cucchiarini, Magali, Kammer, Andreas R., Grabscheid, Benno, Diepolder, Helmut M., Gerlach, Tilman J., Grüner, Norbert, Santantonio, Teresa, Reichen, Jürg, Pape, Gerd R., Cerny, Andreas

Source: In Cellular Immunology 1 August 2000 203(2):111-123

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.